However, it was recently shown that a paclitaxel-resistant NSCLC adenocarcinoma cell line with increased βIII expression was sensitive to vinblastine and its analogs to the same extent as “parental” cells with low taxane resistance and lower βIII expression [235]. This evidence concerns the gene CACNA1B and adenocarcinoma.